TRINITY BIOTECH PLC's ticker is TRIB and the CUSIP is 896438306. A total of 27 filers reported holding TRINITY BIOTECH PLC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $3,000 | -25.0% | 3,209 | 0.0% | 0.00% | – |
Q3 2019 | $4,000 | -20.0% | 3,209 | 0.0% | 0.00% | – |
Q2 2019 | $5,000 | -44.4% | 3,209 | 0.0% | 0.00% | – |
Q1 2019 | $9,000 | +28.6% | 3,209 | 0.0% | 0.00% | – |
Q4 2018 | $7,000 | -46.2% | 3,209 | 0.0% | 0.00% | – |
Q3 2018 | $13,000 | -18.8% | 3,209 | 0.0% | 0.00% | – |
Q2 2018 | $16,000 | -5.9% | 3,209 | 0.0% | 0.00% | – |
Q1 2018 | $17,000 | +6.2% | 3,209 | 0.0% | 0.00% | – |
Q4 2017 | $16,000 | -11.1% | 3,209 | 0.0% | 0.00% | – |
Q3 2017 | $18,000 | -5.3% | 3,209 | 0.0% | 0.00% | – |
Q2 2017 | $19,000 | -34.5% | 3,209 | -33.9% | 0.00% | – |
Q1 2017 | $29,000 | -96.3% | 4,852 | -95.9% | 0.00% | -100.0% |
Q4 2016 | $787,000 | -88.2% | 117,616 | -76.7% | 0.00% | -85.7% |
Q3 2016 | $6,660,000 | -19.2% | 503,782 | -30.7% | 0.01% | -22.2% |
Q2 2016 | $8,242,000 | -30.3% | 726,778 | -28.4% | 0.01% | -30.8% |
Q1 2016 | $11,830,000 | -9.3% | 1,014,616 | -8.5% | 0.01% | -18.8% |
Q4 2015 | $13,045,000 | +144844.4% | 1,109,258 | +282874.0% | 0.02% | – |
Q3 2013 | $9,000 | – | 392 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ACK Asset Management | 928,000 | $10,616,000 | 4.44% |
GOLDMAN CAPITAL MANAGEMENT INC | 350,961 | $4,015,000 | 2.86% |
Paradice Investment Management LLC | 992,235 | $11,351,000 | 2.07% |
Centaur Capital | 77,500 | $887,000 | 1.33% |
Adirondack Funds | 302,305 | $3,458,000 | 1.33% |
Adirondack Research & Management Inc. | 302,305 | $3,458,000 | 1.33% |
RK Capital | 565,472 | $6,469,000 | 1.18% |
Lyon Street Capital, LLC | 140,943 | $1,612,000 | 1.17% |
Benchmark Capital Advisors | 89,941 | $1,029,000 | 0.84% |
KEANE CAPITAL MANAGEMENT INC | 55,045 | $630,000 | 0.83% |